Home Biosimilar Antibodies Immunology & Inflammation TLR antibody Tomaralimab (Anti-TLR2 / CD282) For research use only.
Not for use in humans.

Tomaralimab (Anti-TLR2 / CD282)

Synonyms: OPN-305

Tomaralimab (Anti-TLR2 / CD282) is a humanized immunoglobulin (Ig) G4 monoclonal antibody directed against toll-like receptor type 2 (TLR2) with potential anti-inflammatory and antineoplastic activities. It has the potential for research on Myelodysplastic Syndromes (MDS). MW : 145.5 KD.

Tomaralimab (Anti-TLR2 / CD282)

Purity & Quality Control

≥99

Choose Selective TLR Inhibitors

Biological Activity

Description Tomaralimab (Anti-TLR2 / CD282) is a humanized immunoglobulin (Ig) G4 monoclonal antibody directed against toll-like receptor type 2 (TLR2) with potential anti-inflammatory and antineoplastic activities. It has the potential for research on Myelodysplastic Syndromes (MDS). MW : 145.5 KD.

Product Details

CAS No. 1449294-76-1
Molecular Weight 145.5 kDa
Isotype Human IgG4SP
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Tomaralimab (Anti-TLR2 / CD282) | Tomaralimab (Anti-TLR2 / CD282) supplier | purchase Tomaralimab (Anti-TLR2 / CD282) | Tomaralimab (Anti-TLR2 / CD282) cost | Tomaralimab (Anti-TLR2 / CD282) manufacturer | order Tomaralimab (Anti-TLR2 / CD282) | Tomaralimab (Anti-TLR2 / CD282) distributor